New research suggests that an overactive immune sensor may play a major role in severe genetic disorders linked to rapid aging. By reducing the activity of this sensor, scientists were able to improve tissue health across several biological systems, challenging long-held ideas about how DNA damage drives degeneration.
The immune system is designed to recognize and eliminate threats such as viruses. But under certain conditions, that protective machinery can mistakenly react to the body’s own damaged DNA. When fragments of DNA are treated as if they came from an invading virus, the resulting immune response can trigger chronic inflammation that harms healthy tissue.
An international research team led by Dr. Marva Bergman and Prof. Itamar Harel at Hebrew University, working with Prof. Yehuda Tzfati, Prof. Ido Ben-Ami (Hebrew University and Sha’are Zedek Medical Center), and Prof. Bérénice Benayoun (University of Southern California), found that this misplaced immune reaction is a major contributor to tissue degeneration in severe, rapid-aging disorders.
When the researchers reduced this immune false alarm, they saw improvements across multiple biological systems.
Rethinking DNA Damage and Rapid Aging
The study focused on rare DNA damage-repair (DDR) syndromes such as Ataxia-Telangiectasia (A-T) and Bloom syndrome. In these disorders, the cellular systems responsible for repairing routine DNA damage do not work properly.
As a result, damaged DNA can accumulate throughout the body, creating genomic instability and contributing to neurodegeneration, increased cancer risk, and premature aging.
For decades, researchers largely assumed that the unrepaired DNA itself was the main force driving cellular decline. The new findings suggest the picture is more complicated.
“Our results show that the damage isn’t acting alone,” said Prof. Harel. “It’s the body’s response to that damage, an exaggerated, chronic inflammatory reaction, that drives much of the degeneration.”
When Damaged DNA Triggers an Immune False Alarm
When DNA repair breaks down, pieces of DNA can escape into the cell’s cytosol. Once there, they can activate a molecular sensor called cGAS.
Under normal circumstances, cGAS helps defend the body by detecting viral DNA. The problem is that the sensor cannot always distinguish foreign genetic material from fragments of the body’s own DNA.
That confusion can lead to persistent sterile inflammation, meaning inflammation that occurs without an infection. Instead of protecting the body, the prolonged immune response begins damaging tissues.
The researchers also identified another unexpected role for cGAS.
In addition to activating inflammation, cGAS can move into the cell nucleus and directly disrupt DNA repair. That means the same molecule can contribute to degeneration in two ways: by promoting inflammation and by interfering with the cellular machinery that fixes damaged DNA.
Under normal conditions, cGAS is an important part of the body’s defenses. But when DNA damage becomes overwhelming, its activity may become harmful.
Turning Down cGAS Restored Tissue Function
To determine whether reducing this response could change the course of disease, the researchers used a fast-aging vertebrate model that makes it possible to study aging-related biological changes over a relatively short period.
When cGAS activity was lowered, several major disease features improved. These included neuroinflammation, tissue degeneration, and loss of reproductive capacity.
“We weren’t just slowing decline,” said Dr. Bergman. “We saw broad restoration of tissue function. It suggests that the body can cope with more DNA damage than we assumed, if the inflammatory response is kept in check.”
The results raise the possibility that treating disorders caused by DNA damage may not require repairing every individual DNA lesion.
Instead, future therapies could potentially focus on controlling how the body responds to that damage.
A Potential New Treatment Strategy
That approach could offer a different way to treat severe DNA repair disorders. Rather than trying to correct every damaged piece of genetic material, researchers may be able to reduce the harmful inflammatory reaction that follows.
There is an important complication, however. cGAS is also essential for detecting viral infections, so simply shutting the pathway down could weaken antiviral immunity.
Any future treatment would therefore need to reduce the damaging effects of cGAS without eliminating its protective role.
The findings may also have implications beyond rare genetic conditions. Chronic inflammation and genomic instability are both common features of many age-related diseases, raising the possibility that similar mechanisms could contribute to broader forms of degeneration.
Aging, Reproduction, and Long-Term Health
Other studies from the same research group have explored how basic biological programs, including reproduction and developmental timing, interact with aging and lifespan.
Taken together, the work supports a broader idea: biological systems that help organisms survive, grow, and reproduce early in life may also influence how long tissues remain healthy later on.
The researchers emphasize that reversing severe disease-related degeneration is not the same as slowing the fundamental biological rate of aging.
Even so, the study points to a potentially important shift in how scientists think about DNA damage. The damage itself may be only part of the problem. The body’s own response to that damage can also drive decline, and controlling that response could open new possibilities for treating some of the most difficult degenerative disorders.
